Phase 4 Acute Coronary Syndrome Clinical Trials

19 recruitingPhase 4

What is a Phase 4 trial?

Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.

Showing 119 of 19 trials

Recruiting
Phase 4

MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study

Acute Coronary Syndrome
CHA University490 enrolled9 locationsNCT06543082
Recruiting
Phase 4

INSIGHTFUL-FFR Clinical Trial

Acute Coronary SyndromeCoronary Artery Disease
CoreAalst BV2,500 enrolled29 locationsNCT05437900
Recruiting
Phase 4

Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

Acute Coronary SyndromeMyocardial InfarctionCoronary Artery Disease+1 more
Duk-Woo Park, MD3,320 enrolled43 locationsNCT04416581
Recruiting
Phase 4

The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients

Acute Coronary SyndromeHelicobacter Pylori Infection
Qilu Hospital of Shandong University2,600 enrolled42 locationsNCT04728516
Recruiting
Phase 4

Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome

Acute Coronary Syndromes
King Edward Medical University152 enrolled1 locationNCT06765265
Recruiting
Phase 4

Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients with Acute Coronary Syndromes Treated with Percutaneous Coronary Intervention and Everolimus-eluting Stents

Acute Coronary Syndrome
Odense University Hospital3,150 enrolled3 locationsNCT06718179
Recruiting
Phase 4

Sequential MonotherApy of TicagrElor and Clopidogrel After Coronary Intervention

Acute Coronary SyndromePercutaneous Coronary Intervention
Second Affiliated Hospital, School of Medicine, Zhejiang University2,690 enrolled1 locationNCT04937699
Recruiting
Phase 4

Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention

Acute Coronary SyndromeInterventional Cardiology
Fu Wai Hospital, Beijing, China1,220 enrolled1 locationNCT04240834
Recruiting
Phase 4

A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients

Acute Coronary Syndrome Patients With Diabetes After PCI
Shanghai Tong Ren Hospital40 enrolled1 locationNCT04307511
Recruiting
Phase 4

NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI

Acute Coronary SyndromeCoronary Artery DiseasePercutaneous Coronary Intervention
China National Center for Cardiovascular Diseases3,944 enrolled1 locationNCT05638867
Recruiting
Phase 4

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

Atrial FibrillationStrokeAcute Coronary Syndrome+8 more
St. Antonius Hospital2,000 enrolled20 locationsNCT04436978
Recruiting
Phase 4

Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

Atrial FibrillationAcute Coronary SyndromeAntithrombotic Therapy+1 more
Medical University of Gdansk2,230 enrolled1 locationNCT04695106
Recruiting
Phase 4

Biomarker-guided Management Following a Heart Attack

Secondary prevention post-acute coronary syndromesCardiovascular Disease
Professor Rob Doughty1,028 enrolled1 locationACTRN12619001445167
Completed
Phase 4

Biomarker-Guided Risk Management for Secondary Prevention following Acute Coronary Syndromes: a Feasibility Study

Secondary prevention post-acute coronary syndrome
Professor Rob Doughty100 enrolled1 locationACTRN12618002005235
Terminated
Phase 4

Do new blood-thinning treatments commenced after cardiac surgery keep By-Pass Grafts open longer ?

Coronary Artery Graft Patency following Coronary Artery Bypass Graft (CABG) post Acute Coronary Syndrome (ACS)
Waikato District Health Board400 enrolled2 locationsACTRN12613001362785
Not Yet Recruiting
Phase 4

Ticagrelor and platelet reactivity in acute coronary syndromes

Acute Coronary Syndrome
Peter Larsen50 enrolled1 locationACTRN12613001208796
Completed
Phase 4

Individualised versus conventional enoxaparin dosing: a randomised controlled trial

Atrial FibrillationPulmonary EmbolismAcute Coronary Syndrome+1 more
School of Pharmacy140 enrolled2 locationsACTRN12608000573358
Completed
Phase 3Phase 4

Does point of care troponin testing speed up care of cardiac patients in emergency?

Possible Acute Coronary Syndrome in emergency patients
Conrad Loten300 enrolled1 locationACTRN12607000475448
Completed
Phase 4

THE IMPACT OF THREE DIFFERENT GLYCOPROTEIN PLATELET RECEPTOR IIb/IIIa ANTAGONISTS ON GLYCOPROTEIN IIb/IIIa PLATELET RECEPTOR INHIBITION AND CLINICAL ENDPOINTS IN PATIENTS WITH ACUTE CORONARY SYNDROMES

Assessing patients presenting with acute coronary syndromes, aiming to reduce adverse cardiac outcomes.
A/Professor Craig Juergens210 enrolled1 locationACTRN12607000328471